Clearmind Medicine Inc. (CMND) vs Lakewood-Amedex Biotherapeutics, Inc. (LABT)
A side-by-side comparison of Clearmind Medicine Inc. and Lakewood-Amedex Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMND
Clearmind Medicine Inc.
$5.73HealthcareDelayed quote: Oct 6, 2026, 10:32 AM EDT
LABT
Lakewood-Amedex Biotherapeutics, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 10:31 AM EDT
Total return — CMND vs LABT
growth of $100 · dividends reinvested · last 1yCMND -90.8% (-90.8%/yr)LABT -99.0% (-99.0%/yr)CMND compounded faster over this window
Log scale — wide-divergence pair
CMND LABT
CMND vs LABT: by the numbers
- •LABT is the larger company ($1M vs $1M market cap).
Metrics side by side
Valuation
| Metric | CMND | LABT |
|---|---|---|
| P/B ratio | 0.08 | 0.34 |
Profitability
| Metric | CMND | LABT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -57.87% | -169.64% |
| ROIC | -60.41% | -163.98% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.